Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
BPMC | Blueprint Medicines Corp | Chief Executive Officer | $13.9M | -$1.13M | -7.52% | Mar 7, 2024 |
BCAX | Bicara Therapeutics Inc. | Director | Sep 12, 2024 | |||
FULC | Fulcrum Therapeutics, Inc. | Director | Jun 17, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|